Navigation Links
Biomedical research profits from the exploration of the deep sea
Date:11/19/2008

A study published in the scientific journal PLoS ONE highlights how the exploration of the ocean depths can benefit humankind. This is the story of a voyage of discovery, starting with marine animals that glow, the identification of the molecules responsible and their application as marker in living cells.

Many marine organisms such as sea anemones and corals produce fluorescent proteins, which come in a variety of dazzling hues. Fluorescent proteins have revolutionized biomedical research by enabling the imaging of processes within living cells and tissues. The impact of this technology is considered so high that the 2008 Nobel Prize in Chemistry was most recently awarded to scientists that discovered and further developed the first green fluorescent protein that was applied as cellular marker.

Many useful fluorescent proteins have been found in species that live in the sun-drenched tropical coral reefs. But much less is known about species living in the darkness of the deep sea.

An international team of scientists led by Jrg Wiedenmann of the National Oceanography Centre, Southampton, Mikhail Matz of the University of Texas in Austin and Charles Mazel from the company NightSea have explored the Gulf of Mexico using a submarine, the US Johnson-Sea-Link II, equipped with a system designed to detect fluorescence.

They discovered a species of a sea anemone-like animal (a ceriantharian, or tube anemone) possibly a new species that emits bright green fluorescence. They went on to identify a novel green fluorescent protein.

Although isolated from an animal that lives in essentially complete darkness at depths between 500 and 600 metres and at low temperatures (below 10 C), the new fluorescent protein, named cerFP505, can be well applied as marker protein in mammalian cells at normal body temperature (37 C).

The brightness and stability of cerFP505 are similar to other fluorescent proteins used in biom
'/>"/>

Contact: Rebecca Walton
rwalton@plos.org
Public Library of Science
Source:Eurekalert

Page: 1 2

Related biology news :

1. Boston University biomedical engineers find chink in bacterias armor
2. $22 million gift from Alfred Taubman launches new biomedical research institute
3. USC biomedical team to participate in $6 million low vision project
4. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
5. UVa biomedical engineering study shows magnetic field can reduce swelling
6. Springer expands publishing partnership with the Biomedical Engineering Society
7. NJIT biomedical engineer receives NSF Career Development Award
8. Johnson & Johnson honors 2008 recipients of the Dr. Paul Janssen Award for Biomedical Research
9. Supercomputer provides massive computational boost to biomedical research at TGen
10. Biomedical engineers detective work reveals antibiotic mechanism
11. Research shows skeleton to be endocrine organ

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., The National Association of Biology Teachers (N...r of biological sciences at Naugatuck Valley Commu...h the 2009 Evolution Education Award during the NA...e held 11-14 November 2009 in Denver, Colorado. ,...the American Institute of Biological Sciences,(AI...
(Date:11/4/2009)..., Heavy traffic corridors in the cities of Long B...nt proportion of preventable childhood asthma, and...ns on the disease has likely been underestimated, ...hern California (USC). , The study, which appea...f Public Health , estimated that nine percent of a...
(Date:11/4/2009)..., PORTOLA VALLEY, Calif., Oct. 19 /PRNewswire...ced molecular sensing and imaging devices which sh...oday that it has signed exclusive distribution dea...nd Sensors. The markets covered include Australia...rg (Benelux), Suriname, Italy, France, Spain, Port...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USC study finds big air pollution impacts on local communities 2Spectros Signs New International Distribution Deals 2Medical ethics experts identify address key issues in H1N1 pandemic 58211 1Medical ethics experts identify address key issues in H1N1 pandemic 58211 2Medical ethics experts identify address key issues in H1N1 pandemic 58211 3Medical ethics experts identify address key issues in H1N1 pandemic 58211 4Medical ethics experts identify address key issues in H1N1 pandemic 58211 5Medical ethics experts identify address key issues in H1N1 pandemic 58211 6Medical ethics experts identify address key issues in H1N1 pandemic 58211 7Medical ethics experts identify address key issues in H1N1 pandemic 58211 8Medical ethics experts identify address key issues in H1N1 pandemic 58211 9Physicists at UC Santa Barbara make discovery in quantum mechanics 14243 1Physicists at UC Santa Barbara make discovery in quantum mechanics 14243 2Governor Howard Dean to Discuss Health Care Reform at Philadelphia and New York City Book Signing Appearances 58207 1
...ich are typically used as anti-cholesterol medicat... C virus (HCV). They could replace ribavirin in co...are published in the July 2006 issue of Hepatology... for the Study of Liver Diseases (AASLD). Publishe...ailable online via Wiley InterScience at http://w...
...uch as monkeys which have exceptionally large brai...e study, carried out by Dr Susanne Shultz, from th...ors from Africa and South America such as the jagu...that prey with a small brain such as small antelop...ptible to attacks by predators compared with large...
... display a dramatic reduction of cancer-causing ge...vate the expression of protective microRNAs in the...e June issue of Cancer Cell, demonstrates that age...act regulatory RNAs that may function as tumor sup...tegy for treating human cancers. , DNA methylation...
Other Biology News:Statins stop hepatitis C virus from replicating 2Activation of microRNA inhibits cancer gene in human cancer cells 2
(Date:11/6/2009)...Y., Nov. 6 BioSpecifics ...utical company developing first-in-class collagena...esults for the third quarter ended September 30, 2...ember of this year, the FDA,s Arthritis Advisory C...0, the approval of XIAFLEX(TM) for the treatment o...
(Date:11/6/2009)...Y, Calif., Nov. 6 Calbiotech, Inc....Business Innovative Research (SBIR) Phase I contra...command. Under terms of the agreement, Calbiotech ...the diagnosis of Dengue virus. ,, Dengue vir... major threat to military forces deployed to tropi...
(Date:11/5/2009)..., Md., Nov. 5 GenVec, In...results for the third quarter ended September 30, ...$0.04 per share) for the three months ended Septem...n ($0.08 per share) in the comparable quarter of 2... GenVec,s net loss was $14.1 million ($0.15 per sh...
(Date:11/5/2009)...all on Thursday, November 5, 2009 at 4:30 p.m. Eas.../PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals...XI ) today reported unaudited financial results fo...r 30, 2009 and reviewed the Company,s highlights f...consolidated results reflect the operations of Onc...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...Boston-based interactive marketing and Web develop...ebsite for Anika Therapeutics - www.anikatherapeu...ops products that address the fast-growing joint h...adhesion markets. The company worked with Pixel Br...w site. , Boston, MA (PRW...
... of Standards and Technology (NIST) and the Joint ... the University of Maryland and NIST, have reporte...ntum dots by manipulating them with pairs of laser...Letters ,* could significantly improve quantum dot...perty with important applications in quantum infor...
...ident and CEO,of the Pharmagistics Group, the prem...delivered messages and solutions for the biopharma...E magazine as one of the 100 most,inspiring and in...gistics,Group is a suite of four companies within ...e honor was announced in the July/August issue of ...
Other Biology Technology:Pixel Bridge Works With Anika Therapeutics to Launch New Website 2Pixel Bridge Works With Anika Therapeutics to Launch New Website 3Light touch: Controlling the behavior of quantum dots 2Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences 2Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences 3
Goat Anti-ZBP-89 (S-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Enolase from baker's yeast (S. cerevisiae) from Sigma-Aldrich
UNOsphere S Support, 100 ml from Bio-Rad
Baker's yeast (S. cerevisiae) Phosphoglucose isomerase from Sigma-Aldrich
Biology Products: